Circulating Osteogenic Progenitor Cells Enhanced with Teriparatide or Denosumab Treatment

Circulating osteogenic precursor (COP) cells are peripheral blood cells with a capacity for osteogenesis. The objective of our study was to ascertain the percentage of COPs as an early biomarker of osteoporosis and the effect of these cells in response to Denosumab (DmAb) (anti-resorptive) or to Ter...

Descripción completa

Detalles Bibliográficos
Autores principales: Giner, Mercè, Vázquez-Gámez, María Angeles, Miranda, María José, Bocio-Nuñez, Jesús, Olmo-Montes, Francisco Jesús, Rico, Miguel Angel, Colmenero, Miguel Angel, Montoya-García, María-José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409740/
https://www.ncbi.nlm.nih.gov/pubmed/36012987
http://dx.doi.org/10.3390/jcm11164749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409740/
https://www.ncbi.nlm.nih.gov/pubmed/36012987
http://dx.doi.org/10.3390/jcm11164749

Ejemplares similares